Effects of nicotinamide and carbogen on oxygenation in human tumor xenografts measured with luminescense based fiber-optic probes
- 1 October 2000
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 57 (1) , 21-30
- https://doi.org/10.1016/s0167-8140(00)00275-9
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Optical Sensor-Based Oxygen Tension Measurements Correspond with Hypoxia Marker Binding in Three Human Tumor Xenograft LinesRadiation Research, 2000
- Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamideRadiotherapy and Oncology, 1999
- Clinical Outcome and Tumour Microenvironmental Effects of Accelerated Radiotherapy with Carbogen and NicotinamideActa Oncologica, 1999
- Inducible Repair and the Two Forms of Tumour Hypoxia - Time for a Paradigm ShiftActa Oncologica, 1999
- New insights into factors influencing the clinically relevant oxygen enhancement ratioRadiotherapy and Oncology, 1998
- Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenograftsBritish Journal of Cancer, 1998
- Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime.Radiation Research, 1997
- Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neckInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liverBritish Journal of Cancer, 1995
- SR 4233 (Tirapazamine): a new anticancer drug exploiting hypoxia in solid tumoursBritish Journal of Cancer, 1993